Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rosuvastatin ORBITAL Germany

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00379249
First received: September 20, 2006
Last updated: March 25, 2009
Last verified: March 2009